Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received May 21, 2007
- Revision received July 30, 2007
- Accepted August 2, 2007
- Published online November 1, 2007.
Copyright & Usage
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- YING SUN,
- EHRENTRAUD J. EICHELBAUM,
- HAI WANG and
- DAVID L. VESELY
- Departments of Internal Medicine, Molecular Pharmacology and Physiology, University of South Florida Cardiac Hormone Center and James A. Haley Veterans Medical Center, Tampa, FL, U.S.A.
- Correspondence to: David L. Vesely, MD, Ph.D., Professor of Internal Medicine, Molecular Pharmacology and Physiology, Director, USF Cardiac Hormone Center, J. A. Haley Veterans Medical Center-151, 13000 Bruce B. Downs Blvd., Tampa, Florida 33612, U.S.A. Tel: +1 813 972 7624, Fax: +1 813 972 7623, e-mail: david.vesely{at}va.gov
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer
- Family of Peptides Synthesized in the Human Body Have Anticancer Effects
- Natriuretic Peptides Metabolic Targets for Treatment of Cancer
- Cardiac hormones for the treatment of cancer
- New Anticancer Agents: Hormones Made within the Heart
- Cardiac Hormones Are c-Jun-N-Terminal Kinase 2-inhibiting Peptides
- Four Cardiac Hormones Cause Death of Human Cancer Cells but Not of Healthy Cells
- Twice-weekly Intravenous Treatment of Pancreatic Cancer with Atrial Natriuretic Peptide and Vessel Dilator
- Atrial Natriuretic Peptide and Long-acting Natriuretic Peptide Inhibit Ras in Human Prostate Cancer Cells
- Cardiac and Renal Hormones: Anticancer Effects In Vitro and In Vivo